Editor's columnThe enigma of persistent hyperinsulinemic hypoglycemia of infancy
References (18)
- et al.
Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment with-out pancreatectomy
J Pediatr
(1993) Hypoglycemia in infants and children
Endocrinol Metab Clin North Am
(1989)- et al.
Management of hyperinsulinism in infants
J Pediatr
(1991) - et al.
Familial hyperinsulinism: successful conservative management
J Pediatr
(1991) - et al.
Glycemic response to glucagon during fasting: an aid in the diagnosis of hyperinsulinism
J Pediatr
(1980) - et al.
Linear growth during longterm treatment with somatostatin analog (SMS 201-995) for persistent hyperinsulinemic hypoglycemia of infancy
J Pediatr
(1990) - et al.
Familial and sporadic hyperinsulinism: histopathologic findings and segregation analysis suggest a single autosomal recessive disorder
J Pediatr
(1991) - et al.
Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism
J Pediatr
(1993) Recent advances in hyperinsulinism and the pathogenesis of diabetes mellitus
Current Opinion in Pediatrics
(1990)
Cited by (23)
Laparoscopic vs open pancreatectomy for persistent hyperinsulinemic hypoglycemia of infancy
2009, Journal of Pediatric SurgeryCitation Excerpt :All patients had 98% pancreatectomy at the redo-surgery. Persistent hyperinsulinemic hypoglycemia of infancy is a rare congenital disease of glucose metabolism [2]. It is believed that an abnormal regulation of B-islet cell production of insulin is responsible for the hyperinsulinemia that characterizes this disease [13-15].
Laparoscopic pancreatectomy for persistent hyperinsulinemic hypoglycemia of infancy
2009, Journal of Pediatric SurgeryCitation Excerpt :Three (30%) patients have moderate to severe developmental delay. Persistent hyperinsulinemic hypoglycemia of infancy is a rare congenital disease of glucose metabolism [2]. Abnormal regulation of B-iselt cell production of insulin is thought to be responsible for the hyperinsulinemia that characterizes this disease [13-15].
Persistent hyperinsulinemic hypoglycemia in infants
2003, Newborn and Infant Nursing ReviewsCitation Excerpt :Side effects include fluid retention, and a diuretic medication such as hydroclorothiazide or lasix is sometimes used with Diazoxide in anticipation of this.6,42,44 Octreotride is a long-acting somatostatin analog that also acts to inhibit insulin secretion by activating the beta cell potassium channels, but it involves the possibility of suppression of growth hormone28,44,46–48 abdominal distention, and gallstones.6 Nifedipine is a calcium channel blocking agent and acts to decrease insulin secretion by closing the ATP potassium channels in the pancreatic beta cells.49–51
Congenital hyperinsulinism and the surgeon: Lessons learned over 35 years
1999, Journal of Pediatric SurgerySomatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia
2020, Therapeutic Advances in Endocrinology and Metabolism